Blue Cross and Blue Shield of Illinois policy
Infliximab and Associated Biosimilars
Infliximab and Associated Biosimilars is a public Blue Cross and Blue Shield of Illinois policy (policy RX501.051, effective Jan 1, 2026). It lists 6 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
- Policy number
- RX501.051
- Effective
- Jan 1, 2026
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Blue Cross and Blue Shield of Illinois policies |
|---|---|
| J1745 | Policies naming J1745 |
| J3590 | Policies naming J3590 |
| Q5103 | Policies naming Q5103 |
| Q5104 | Policies naming Q5104 |
| Q5109 | Policies naming Q5109 |
| Q5121 | Policies naming Q5121 |